Guest guest Posted December 24, 2009 Report Share Posted December 24, 2009 http://blogs.mercola.com/sites/vitalvotes/archive/2009/12/23/World-Health-Advisor-Conceals-Millions-of-Dollars-in-Donations-From-Drug-Company.aspx World Health Advisor Conceals Millions of Dollars in Donations From Drug Company Posted by: Dr. Mercola December 23 2009 | 450 views A Finnish member of the World Health Organization board, an advisor on vaccines, has received 6 million euros for his research center from the vaccine manufacturer GlaxoKline. Although WHO promises transparency, this conflict of interests is not available for the public to see at WHO’s homepage. Professor Juhani Eskola is the director of the Finnish research vaccine program and a new member of the WHO group ‘Strategic Advisory Group of Experts’ (SAGE). SAGE recommend which vaccines -- and how many -- member countries should purchase for the pandemic. According to documents acquired through the Danish Freedom of Information Act, Eskola’s Finnish institute, THL, received almost 6.3 million Euro from GlaxoKline (GSK) for research on vaccines during 2009. GlaxoKline produces the H1N1-vaccine ‘Pandemrix,’ which the Finnish government -- following recommendations from THL and WHO -- purchased for a national pandemic reserve stockpile. Several other WHO experts also have financial ties to the pharmaceutical industry -- a double role which notably is not published by WHO. Sources: The Flu Case December 17, 2009 Sheri Nakken, R.N., MA, Hahnemannian Homeopath Vaccination Information & Choice Network, Washington State, USA Vaccines - http://vaccinationdangers.wordpress.com/ Vaccine Dangers, Childhood Disease Classes & Homeopathy Online/email courses - next classes start January 6 & 7 http://www.wellwithin1.com/vaccineclass.htm or http://www.wellwithin1.com/homeo.htm Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.